Trial intelligence / Profile preview

Short versus standard postoperative antibiotics for complex acute appendicitis

NL-OMON45262Active, not recruiting

Sponsor
Erasmus MC
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of cefuroxime and metronidazole in acute appendicitis, sponsored by Erasmus MC. Primary endpoint: Postoperative infectious complications related to appendectomy and mortality. Started Apr 2017; status: active, not recruiting.

02

Drugs

cefuroximemetronidazole
03

Conditions

acute appendicitis

Beyond the preview

Go deeper on NL-OMON45262.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON45262.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call